TY - JOUR
T1 - Distribution of streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics
AU - Mason, Edward O.
AU - Lamberth, Linda
AU - Lichenstein, Rebekah
AU - Kaplan, Sheldon L.
N1 - Funding Information:
The expert organization assistance of Rick Lavender, Medex, Inc., Ardmore, PA is greatly appreciated. This study was supported in part by a grant from Bristol-Myers Squibb Company.
Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 1995/12
Y1 - 1995/12
N2 - Surveillance by 33 laboratories in 19 states during a 4 1/2 month period between December 1993 and April 1994 found that 263 of 1627 (16.2%) isolates of Streptococcus pneumoniae were resistant to penicillin. One hundred and seventy (10.4%) isolates were determined to be intermediately resistant to penicillin (MICs 0.1-1.0 mg/L and 93 (5.7%) were found to be highly resistant to penicillin (MICs > 2.0 mg/L). MIC(90s) for intermediately penicillin resistant strains were: amoxycillin/clavulanate 2.0 mg/L, cefaclor 64 mg/L, cefixime 32 mg/L, cefprozil 8 mg/L and loracarbef 128 mg/L. MIC(90s) for highly penicillin resistant strains were: amoxycillin/clavulanate 4.0 mg/L, cefaclor ≥ 128 mg/L cefixime 64 mg/L, cefprozil 32 mg/L and loracarbef ≥ 128 mg/L.
AB - Surveillance by 33 laboratories in 19 states during a 4 1/2 month period between December 1993 and April 1994 found that 263 of 1627 (16.2%) isolates of Streptococcus pneumoniae were resistant to penicillin. One hundred and seventy (10.4%) isolates were determined to be intermediately resistant to penicillin (MICs 0.1-1.0 mg/L and 93 (5.7%) were found to be highly resistant to penicillin (MICs > 2.0 mg/L). MIC(90s) for intermediately penicillin resistant strains were: amoxycillin/clavulanate 2.0 mg/L, cefaclor 64 mg/L, cefixime 32 mg/L, cefprozil 8 mg/L and loracarbef 128 mg/L. MIC(90s) for highly penicillin resistant strains were: amoxycillin/clavulanate 4.0 mg/L, cefaclor ≥ 128 mg/L cefixime 64 mg/L, cefprozil 32 mg/L and loracarbef ≥ 128 mg/L.
UR - http://www.scopus.com/inward/record.url?scp=0029609092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029609092&partnerID=8YFLogxK
U2 - 10.1093/jac/36.6.1043
DO - 10.1093/jac/36.6.1043
M3 - Article
C2 - 8821604
AN - SCOPUS:0029609092
VL - 36
SP - 1043
EP - 1048
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
SN - 0305-7453
IS - 6
ER -